Study of production of β-lactamase and drugs susceptibility in strains of coagulase-negative staphylococci isolated of neonates;Estudo da produção de β-lactamase e sensibilidade às drogas em linhagens de estafilococos coagulase-negativos isolados de recém-nascidos

Jornal Brasileiro de Patologia e Medicina Laboratorial

Volumn 38, Issue 4, 2002, Pages 281-290

  De Souza Da Cunha, Maria De Lourdes Ribeiro ^a   De Magalhães Lopes, Carlos Alberto ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Antimicrobial susceptibility; Coagulase negative; Neonates; Staphylococci

Indexed keywords

EID: 34548819054     PISSN: 16762444     EISSN: 16784774     Source Type: Journal    
DOI: 10.1590/s1676-24442002000400006     Document Type: Article

References (29)

1. Archer, G.L. Molecular epidemiology of multiresistant Staphylococcus epidermidis. J. Antimicrob. Chemother., 21: 33-8, 1988.
2. Archer, G.L. & Scott, J. Conjugative transfer genes in staphylococcal isolates from the United States. Antimicrob. Agents Chemother., 35: 2500-4, 1991.
3. Archer, G.L. & Climo, M.W. Antimicrobial susceptibility of coagulase-negative staphylococci. Antimicrob. Agents Chemother., 38: 2231-7, 1994.
4. Baker, J.S. Comparison of various methods for differentiation of staphylococci and micrococci. J. Clin. Microbiol., 19: 875-9, 1984.
5. Bannerman, T.L.; Wadiac, D.L. & Kloos, W.E. Susceptibility of Staphylococcus species and subspecies to teicoplanin. Antimicrob. Agents Chemother., 35: 1919-22, 1991.
6. Barcs, I.; Vályi-Nagy, T. & Pánovics, J. Clinical occurrence and virulence testing of coagulase-negative staphylococci. Acta Microbiol. Hung.,36: 415-24, 1989.
7. Bergan, T. & Lernestedt, J.O. Antibiotic resistance in staphylococci from a hospital environment. Chemotherapy, 29: 28-36, 1983.
8. Bischoff, M. et al. Involvement of multiple genetic loci in Staphylococcus aureus teicoplanin resistance. FEMS Microb. Let., 194: 77-82, 2001.
9. Evans, J.B.; Bradford Junior, W.L. & Niven Junior, C.F. Comments concerning the taxonomy of the genera micrococcus and staphylococcus. Int. Bull. Bacteriol. Nomencl. Taxon., 5: 61-6, 1955.
10. Golledge, C.L. Staphylococcus saprophyticus bacteremia. J. Infect. Dis., 157: 215, 1988.
11. Grosserode, M.H. & Wenzel, R.P. The continuing importance of staphylococci as major hospital pathogens. J. Hosp. Infect., 19: 3-17, 1991.
12. Hudome, S.M. & Fisher, M.C. Nosocomial infections in the neonatal intensive care. Curr. Op. in Infect. Dis., 14: 303-7, 2001.
13. Hussain, Z. et al. Comparison of the MicroScan system with the "API Staph-Ident" system for species identification of coagulase-negative staphylococci. J. Clin. Microbiol., 23: 126-8, 1986.
14. Jones, R.N. Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients. Am. J. Med., 100: 1-12, 1996.
15. Jordan, P.A. et al. Urinary tract infection caused by Staphylococcus saprophyticus. J. Infect. Dis., 142: 510-5, 1980.
16. Kloos, W.E. & Schleifer, K.H. Simplified scheme for routine identification of human Staphylococcus species. J. Clin. Microbiol., 1: 82-8, 1975.
17. Kloos, W.E. & Bannerman, T.L. Update on clinical significance of coagulase-negative staphylococci. Clin. Microbiol. Rev., 7: 117-40, 1994.
18. Kloos, W.E. & Bannerman, T.L. Staphylococcus and Micrococcus. In: Murray, P.R. et al. (ed.) Manual of Clinical Microbiology. 6. ed. Washington: American Society Microbiology, 1995. p. 282-98.
19. Kotilainen, P.; Nikoskelainen, J. & Huovinen, P. Antibiotic susceptibility of coagulase-negative staphylococcal blood isolates with special reference to adherent, slime-producing Staphylococcus epidermidis strains. Scand. J. Infect. Dis., 23: 325-32, 1991.
20. Large, M. et al. A study of coagulase-negative staphylococci isolated from clinically significant infections at an australian teaching hospital. Pathology, 21: 19-22, 1989.
21. Marshall, S.A. et al. Staphylococcus aureus and coagulase-negative staphylococci from blood stream infections: frequency of occurence, antimicrobial susceptibility, and molecular (mecA) characterization of oxacillin resistance in the SCOPE program. Diagn. Microbiol. Infect. Dis., 30: 205-14, 1998.
22. Mcdonnell, R.W.; Sweeney, H.M. & Cohen, S. Conjugational transfer of gentamicin resistance plasmids intra- and interspecifically in Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob. Agents Chemother., 23: 151-60, 1983.
23. Mctaggart, L.A. & Elliott, T.S.J. Is resistance to novobiocin a reliable test for confirmation of the identification of Staphylococcus saprophyticus? J. Med. Microbiol., 30: 253-66, 1989.
24. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial disk susceptibility tests. Approved Standard M2-A7. 7. ed. Villanova, 2000.
25. Nickel, J.C. & Costerton, J.W. Coagulase-negative Staphylococcus in chronic prostatitis. J. Urol., 147: 398-401, 1992.
26. Pfaller, M.A. & Herwaldt, L.A. Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clin. Microbiol. Rev., 1: 281-99, 1988.
27. Refsahl, K. & Andersen, B.M. Clinically significant coagulasenegative staphylococci: identification and resistance patterns. J. Hosp. Infect., 22: 19-31, 1992.
28. Schaberg, D.R., Culver, D.H. & Gaynes, R.P. Major trends in the microbial etiology of nosocomial infection. Am. J. Med., 91: 72-5, 1991.
29. Veach, L.A. et al. Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection. J. Clin. Microbiol., 28: 2064-8, 1990.